Humana Stock (NYSE:HUM)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$364.46

52W Range

$163.11 - $372.70

50D Avg

$263.46

200D Avg

$247.22

Market Cap

$44.27B

Avg Vol (3M)

$1.71M

Beta

0.77

Div Yield

$3.54 (0.96%)

HUM Company Profile


Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Show More

Industry

Medical - Healthcare Plans

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

65,680

IPO Date

Dec 31, 1981

Website

HUM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
CenterWell Segment$22.47B$19.94B$18.41B
Insurance Segment$124.56B$113.76B$102.85B
Service--$4.03B

Fiscal year ends in Dec 25 | Currency in USD

HUM Financial Summary


Dec 25Dec 24Dec 23
Revenue$129.66B$117.81B$106.44B
Operating Income$1.45B$1.63B$3.32B
Net Income$1.19B$1.21B$2.49B
EBITDA$2.91B$3.25B$4.73B
Basic EPS$9.87$10.01$20.09
Diluted EPS$9.84$9.98$20.00

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Apr 29, 26 | 12:00 AM
Q4 25Feb 11, 26 | 12:00 AM
Q3 25Nov 05, 25 | 8:00 AM

Peer Comparison


TickerCompany
ONCBeOne Medicines Ltd.
HLNHaleon plc
RMDResMed Inc.
MTDMettler-Toledo International Inc.
INSMInsmed Incorporated
IQVIQVIA Holdings Inc.
AAgilent Technologies, Inc.
GEHCGE HealthCare Technologies Inc.
ALCAlcon Inc.
CNCCentene Corporation